FDA Restricts Obeticholic Acid Over Serious Liver Injury Risk ...Middle East

Obeticholic acid is now contraindicated in patients with primary biliary cholangitis and advanced cirrhosis, following reports of serious liver injury leading to liver decompensation or liver failure. News Alerts

Hence then, the article about fda restricts obeticholic acid over serious liver injury risk was published today ( Wednesday 26/05/2021 - 11:56 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Restricts Obeticholic Acid Over Serious Liver Injury Risk )

Also on site :

• A Recent Tragedy Has Left My Kids Devastated. But I’m Secretly Pleased.
• Watch last video of ‘All That’ star Kianna Underwood who died in hit-and-run at 33
• Refugee-student housing project in EU state rocked by rape scandal